Copyright: ©Author(s) 2026.
World J Methodol. Sep 20, 2026; 16(3): 118520
Published online Sep 20, 2026. doi: 10.5662/wjm.118520
Published online Sep 20, 2026. doi: 10.5662/wjm.118520
Table 2 Mechanisms of anti-obesity drug-induced visual impairment
| Mechanism | Description | Examples |
| Vascular | Ischemia due to altered ocular blood flow or microvascular injury | GLP-1 receptor agonists (NAION) |
| Metabolic | Indirect effects, such as rapid glycemic improvement or hepatic dysfunction | GLP-1 receptor agonists (DR) |
| Direct drug toxicity | Physical or chemical injury to ocular structures | Topiramate (anatomic shift, effusion) |
- Citation: Khullar S, Morya AK, Aggarwal S, Singh A, Sisodiya P, Morya R. Anti-obesity medications impacting the eye: An emerging concern - a narrative review. World J Methodol 2026; 16(3): 118520
- URL: https://www.wjgnet.com/2222-0682/full/v16/i3/118520.htm
- DOI: https://dx.doi.org/10.5662/wjm.118520